Open access
Open access
Powered by Google Translator Translator

All Posts

2023 ACC/AHA/SCAI Advanced training statement on interventional cardiology

21 Feb, 2023 | 11:52h | UTC

Summary: The American College of Cardiology (ACC), the American Heart Association (AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI) have issued a clinical document that outlines competency-based training requirements for interventional cardiology trainees. The report emphasizes the importance of a comprehensive training program that includes both didactic and hands-on training. The competencies required for interventional cardiologists include the ability to perform complex coronary, peripheral vascular, and structural heart interventions and manage and treat complications that may arise during these procedures.

Article: 2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee – Journal of the American College of Cardiology

Commentaries:

Interventional Cardiology Training Needs Defined for the First Time – TCTMD

ACC, AHA, SCAI Release New Training Guidance For Interventional Cardiology – American College of Cardiology

New Advanced Training Statement on Interventional Cardiology: Key Points – American College of Cardiology

 


Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019

22 Feb, 2023 | 12:17h | UTC

Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019 – eClinicalMedicine

 


Sleep irregularity linked to subclinical markers of cardiovascular disease

21 Feb, 2023 | 11:51h | UTC

Summary: The study examined the association between sleep irregularity and subclinical markers of cardiovascular disease in a population of over 2000 participants with a mean age of 68. The participants completed 7-day wrist actigraphy that detected when they were asleep and awake. The results showed that sleep irregularity, particularly sleep duration irregularity, was associated with subclinical atherosclerosis, including high coronary artery calcium burden and abnormal ankle-brachial index. These associations persisted even after adjusting for cardiovascular disease risk factors and other sleep characteristics such as obstructive sleep apnea, sleep duration, and sleep fragmentation. While it is important to note that observational studies like this one cannot establish causation and may be subject to residual confounding, the findings suggest that promoting regular sleep schedules could be an essential aspect of lifestyle recommendations for preventing cardiovascular disease.

Article: Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis – Journal of the American Heart Association

News Release: Irregular sleeping habits may increase risk of atherosclerosis in older adults – American Heart Association

Commentaries:

Study finds chronically disrupted sleep may increase the risk for heart disease – Vanderbilt University Medical Center

Sleep Irregularity Linked to Measures of Subclinical Atherosclerosis – HealthDay

Irregular sleep may be harmful to your heart, study finds – CNN

 


Guideline Synopsis | Management of thoracic aortic dissection

21 Feb, 2023 | 11:48h | UTC

Management of Thoracic Aortic Dissection – JAMA (free for a limited period)

Original Guidelines:

The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection – Annals of Thoracic Surgery

2021 The American Association for Thoracic Surgery expert consensus document: Surgical treatment of acute type A aortic dissection ($)

 


Consensus Statement | Renal denervation in the management of hypertension in adults

21 Feb, 2023 | 11:45h | UTC

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – European Heart Journal

 


Instant noodle burns common in pediatric scald injuries: Study highlights need for prevention efforts

21 Feb, 2023 | 11:50h | UTC

Summary: The study examined pediatric scald burns at the University of Chicago Burn Center between 2010 and 2020 and found that 31% of burns were attributed to instant noodles. Children with instant noodle burns were typically older, more likely to be Black/African American, and from lower socio-economic backgrounds. They were also more likely to be unsupervised at the time of the injury. While instant noodle burns were smaller and required less operative intervention than other scald burns, some still required hospitalization and were associated with complications. The study highlights the need for targeted burn prevention efforts to reduce the incidence of these common but serious injuries.

Article: Pediatric instant noodle burns: A ten-year single center retrospective study – Burns (link to abstract – $ for full-text)

Commentary: Why Instant Noodles Are a Danger to Your Kids – HealthDay

 


M-A | Drugs to reduce bleeding in major open vascular or endovascular surgery – not enough evidence to guide treatment

21 Feb, 2023 | 11:44h | UTC

Summary: The article is a systematic review and network meta-analysis of randomized controlled trials (RCTs) on the effectiveness and safety of anti-fibrinolytic and hemostatic drugs and agents to reduce bleeding and the need for blood transfusion in people undergoing major vascular surgery or endovascular procedures. The authors searched multiple databases and trial registries and included 22 RCTs with 3,393 participants analyzed. Due to a lack of data, the authors are uncertain whether any systemic or topical treatments may improve outcomes, emphasizing that larger trials with clinically relevant outcomes are needed.

Article: Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis – Cochrane Library

 


Cohort Study | One third of patients hospitalized with Covid-19 persist with lung abnormalities after 2 years

21 Feb, 2023 | 11:47h | UTC

Summary: The study aimed to assess changes in chest CT abnormalities and pulmonary function in patients two years after recovery from SARS-CoV-2 infection. The prospective study followed 144 participants discharged from the hospital after SARS-CoV-2 infection between January 15 and March 10, 2020. The participants underwent serial chest CT scans and pulmonary function tests at 6 months, 12 months, and 2 years after symptom onset. The study found that 39% of participants had persistent interstitial lung abnormalities at 2 years, and this was associated with respiratory symptoms and decreased diffusion pulmonary function.

Article: Longitudinal Assessment of Chest CT Findings and Pulmonary Function in Patients after COVID-19 – Radiology

Editorial: Radiologic Findings after COVID-19 and the Correlation with Lung Function – Radiology

Commentaries:

Post-COVID-19 CT scans show lung abnormalities persist two years later – News Medical

COVID’s aftermath: Persistent organ damage at 1 year, lung abnormalities at 2 – CIDRAP

 


Review | How to manage coagulopathies in critically ill patients

21 Feb, 2023 | 11:43h | UTC

How to manage coagulopathies in critically ill patients – Intensive Care Medicine

Related: Approach to the Coagulopathic Patient in the Intensive Care Unit – Indian Journal of Critical Care Medicine

 

Commentary on Twitter

 


Analysis | High drug prices are not justified by industry’s spending on research and development

21 Feb, 2023 | 11:41h | UTC

High drug prices are not justified by industry’s spending on research and development – The BMJ

News Release: Drug prices not justified by industry’s research and development spending – BMJ Newsroom

Commentary: Pharmaceutical companies can develop more innovative and affordable medicines by refocusing their spending but government intervention is needed – London School of Hygiene & Tropical Medicine

 

Commentary from the author on Twitter (thread – click for more)

 


AHA Scientific Statement | Anesthetic care of the pregnant patient with cardiovascular disease

20 Feb, 2023 | 12:29h | UTC

Summary: The AHA emphasizes the need for specialized cardio-obstetric anesthesiology care for pregnant patients with cardiovascular disease, involving a multidisciplinary team of obstetricians, cardiologists, anesthesiologists, and other specialists as needed. The approach includes preoperative evaluation, intraoperative management, and postoperative care to maintain maternal hemodynamic stability, optimize oxygen delivery to the fetus, and avoid factors that exacerbate cardiovascular disease. Vaginal delivery with effective neuraxial analgesia is the preferred mode of delivery, with cesarean delivery used for obstetrical indications or high-risk patients. Specific recommendations are also provided for the management of patients with different types of cardiovascular disease, including congenital heart disease, valvular heart disease, pulmonary hypertension, and hypertrophic cardiomyopathy.

Article: Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation

Top Things to Know: Statement on the anesthetic care of the pregnant patient with cardiovascular disease – American Heart Association

 


Review | Diagnosis and management of patients with polyneuropathy

21 Feb, 2023 | 11:40h | UTC

Diagnosis and management of patients with polyneuropathy – Canadian Medical Association Journal

 


Study finds low rates of antipsychotic medication discontinuation in older adults following infection-related hospitalization

20 Feb, 2023 | 12:25h | UTC

Summary: The study aimed to investigate discontinuation rates of antipsychotic medications (APMs) used to treat delirium due to acute hospitalization and infection in older adults. The cohort study involved 5,835 patients in the US, who were aged 65 years or older, without prior psychiatric disorders and had newly initiated an APM prescription within 30 days of an infection-related hospitalization. The study found that only 11% of new atypical APM users and 52% of new haloperidol users discontinued the medication by 30 days after initiation. The discontinuation of haloperidol and atypical APM was less likely to occur in patients with dementia and prolonged hospitalization. The findings suggest that APM discontinuation rates following infection-related hospitalization are low, especially for atypical APM, and call for effective interventions to proactively discontinue APMs when they are no longer indicated.

Article: Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization – JAMA Network Open

 


RCT | Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease

20 Feb, 2023 | 12:27h | UTC

Summary: The article reports on a randomized trial that compared the effects of alternate-day fasting (ADF) combined with exercise, fasting alone, or exercise alone in adults with obesity and non-alcoholic fatty liver disease (NAFLD). After three months, the combination of ADF and exercise significantly reduced intrahepatic triglyceride content, body weight, fat mass, waist circumference, and alanine transaminase levels compared to the control group. The intervention seems promising for patients with fatty liver disease who want to improve their health without using medications.

Article: Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial – Cell Metabolism (link to abstract – $ for full-text)

News Release: Alternate-day fasting could be a good option for patients with fatty liver disease – University of Illinois Chicago

 


Gadolinium nanoparticles detected in kidney tissue of patients after MRI with gadolinium contrast, raising safety concerns

20 Feb, 2023 | 12:24h | UTC

Summary: Researchers have discovered that tiny particles of the rare earth metal gadolinium can infiltrate kidney cells, potentially causing side effects. These particles, used to enhance MRI scans, were found in human and rodent specimens in a study that used electron microscopy to detect them. Gadolinium is typically tightly bound to chelating molecules in MRI contrast agents so that it can be eliminated via the kidneys, but the researchers found that some particles can leach out and build up in tissues. This raises questions about the safety of contrast agents containing gadolinium, which are used in around 50% of MRI scans, and highlights the need for further research into the risks and potential harms associated with these agents.

Article: The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposure – Scientific Reports

News Release: UNM Researchers Find Nanoparticles of Gadolinium, a Rare Earth Metal Used in MRI Contrast Agents, Can Infiltrate Kidney Tissue – University of New Mexico

Commentary: Expert left ‘astounded’ by gadolinium discovery – Health Imaging

 


M-A | Consumption of whole vs. refined grains and risk of cardiovascular disease and all-cause mortality

20 Feb, 2023 | 12:23h | UTC

Summary: This systematic review and meta-analysis of prospective cohort studies found that consuming whole grains was associated with a reduced risk of coronary heart disease, cardiovascular disease, and all-cause mortality, while consuming refined grains had no significant influence on these outcomes. Residual confounding can’t be excluded and the association found does not necessarily imply causation.

Article: Consumption of whole grains and refined grains and associated risk of cardiovascular disease events and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies – American Journal of Clinical Nutrition

Related: Cohort Study | Associations between types and sources of dietary carbohydrates and cardiovascular disease risk

 


ESPEN practical guideline | Home parenteral nutrition

20 Feb, 2023 | 12:21h | UTC

Summary: Home parenteral nutrition (HPN) is a form of nutrition support where a patient receives intravenous nutrition at home. It is used for patients who cannot receive adequate nutrition through oral or enteral routes, such as those with intestinal failure, severe inflammatory bowel disease, or other gastrointestinal disorders. HPN can be a life-saving therapy, but it requires careful patient selection, as well as ongoing monitoring and management by a multidisciplinary team. The ESPEN guideline aims to provide practical guidance on the use of HPN, including the nutritional and metabolic aspects of care and the practical considerations of administering HPN at home. The guideline also emphasizes the importance of patient-centered care and shared decision-making, highlighting the need for regular assessment and monitoring of patients.

Article: ESPEN practical guideline: Home parenteral nutrition – Clinical Nutrition

 


RCT | Rucaparib vs. physician’s choice in metastatic prostate cancer

20 Feb, 2023 | 12:17h | UTC

Summary: This phase 3 randomized trial compared Rucaparib vs. physician’s choice control (docetaxel or a second-generation ARPI) in treating metastatic, castration-resistant prostate cancer patients with a BRCA1, BRCA2, or ATM alteration who had disease progression after treatment with a second-generation androgen-receptor pathway inhibitor (ARPI). The study found that the duration of radiographic progression-free survival was significantly longer in the rucaparib group than in the control group. The most frequent adverse events with rucaparib were fatigue and nausea.

Article: Rucaparib or Physician’s Choice in Metastatic Prostate Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Rucaparib Efficacious in Metastatic Castration-Resistant Prostate Cancer – HealthDay

 

Commentary on Twitter

 


M-A | General Anesthesia vs. to Non-GA in endovascular thrombectomy for ischemic stroke

20 Feb, 2023 | 12:20h | UTC

Summary: The study analyzed randomized controlled trials comparing the use of general anesthesia (GA) versus non-GA techniques, such as conscious sedation or local anesthesia for endovascular thrombectomy (EVT) in patients with ischemic stroke. The meta-analysis included seven trials with a total of 980 participants, showing that GA is associated with a 9% improvement in recanalization rates and an 8.4% improvement in functional recovery compared to non-GA techniques. There was no difference in hemorrhagic complications or 3-month mortality. The study recommends that GA be the first choice for most EVT procedures in acute ischemic stroke.

Article: General Anesthesia Compared to Non-GA in Endovascular Thrombectomy for Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials – Neurology (link to abstract – $ for full-text)

 


Review | Neurological complications of sepsis

20 Feb, 2023 | 12:16h | UTC

Summary: This article covers the latest developments in the prevention, diagnosis, and treatment of sepsis-associated encephalopathy (SAE) and ICU-acquired weakness (ICUAW). SAE diagnosis is clinical with supporting EEG and neuroimaging. Treatment involves early identification and treatment of infections and organ dysfunction. ICUAW is due to an overlap between critical illness polyneuropathy, critical illness myopathy, and muscle disuse atrophy. It affects all limbs and respiratory muscles and is associated with prolonged hospital stay, increased costs, and both short and long-term mortality. Recovery is typical in weeks or months, but severe cases may result in persistent functional impairments for ICU survivors.

Article: Neurological complications of sepsis – Current Opinion in Critical Care

 


M-A | Soluble fiber supplementation and serum lipid profile

20 Feb, 2023 | 12:18h | UTC

Summary: The article presents the results of a systematic review and dose-response meta-analysis of randomized controlled trials (RCTs) that evaluated the effect of soluble fiber supplementation on blood lipid parameters in adults. The review included 181 RCTs with 220 treatment arms and 14,505 participants. The meta-analysis found that soluble fiber supplementation significantly reduced LDL cholesterol, total cholesterol, triglycerides, and apolipoprotein B concentrations. The article suggests that increasing fiber intake using soluble fiber supplementation could be an effective intervention in the prevention and management of dyslipidemia, and consequently may contribute to the risk reduction of cardiovascular diseases. However, the article also notes that because of the high between-study heterogeneity and publication bias, the findings should be interpreted cautiously.

Article: Soluble Fiber Supplementation and Serum Lipid Profile: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials – Advances in Nutrition

 


Phase 2b RCT | Ad26.RSV.preF–Respiratory Syncytial Virus preF protein vaccine is immunogenic in older adults

17 Feb, 2023 | 13:30h | UTC

Summary: A phase 2b clinical trial evaluated the Ad26.RSV.preF–RSV preF protein vaccine’s efficacy, immunogenicity, and safety in preventing RSV-mediated lower respiratory tract disease in adults aged 65 years and older. The vaccine was effective in preventing the disease and immunogenic, as demonstrated by the increase in RSV A2 neutralizing antibody titers after vaccination. The vaccine was associated with higher rates of adverse events than the placebo, but most were of mild to moderate severity. The trial concluded that Ad26.RSV.preF–RSV preF protein vaccine was effective in preventing RSV-mediated lower respiratory tract disease in older adults.*

Article: Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Ad26.RSV.preF-RSV preF Protein Vaccine Immunogenic in Seniors – HealthDay

 

*Note: This summary was created through the collaboration of a medical editor and ChatGPT.

 


RCT | Respiratory Syncytial Virus prefusion F protein vaccine provides protection for older adults

17 Feb, 2023 | 13:32h | UTC

Summary: A phase 2b clinical trial evaluated the Ad26.RSV.preF–RSV preF protein vaccine in adults aged 65 years and older. The vaccine was effective and immunogenic, as demonstrated by the increase in RSV A2 neutralizing antibody titers after vaccination. The vaccine was associated with higher rates of adverse events than the placebo, but most were of mild to moderate severity.*

Article: Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 

*Note: This summary was created through the collaboration of a medical editor and ChatGPT.

 


RCT | Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age

17 Feb, 2023 | 13:27h | UTC

Summary: The study was a combined phase 2-3 clinical trial that aimed to determine whether the BNT162b2 vaccine was safe, could elicit an immune response and was effective in preventing COVID-19 in healthy children. The trial was conducted on children aged 6 months to 11 years, with the findings presented for the 6 months to 4 years age group. The results indicated that the vaccine was safe, immunogenic, and effective in reducing the risk of symptomatic COVID-19 by 73.2% in children aged 6 months to 4 years. The vaccine was well-tolerated, and the side effects were mainly mild to moderate. The incidence of fever was similar among those who received the vaccine or a placebo.*

Article: Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age – New England Journal of Medicine (link to abstract – $ for full-text)

 

*Note: This summary was created through the collaboration of a medical editor and ChatGPT.

 


RCT | Breast-conserving surgery without irradiation may be an option for older patients with early breast cancer

17 Feb, 2023 | 13:25h | UTC

Summary: The article reports a phase 3 randomized trial that investigated the efficacy of omitting irradiation after breast-conserving surgery in women aged 65 years or older with hormone receptor-positive, node-negative, T1 or T2 primary breast cancer, and tumors ≤3 cm in the largest dimension, who received adjuvant endocrine therapy. A total of 1326 women were enrolled, with 658 receiving whole-breast irradiation and 668 receiving no irradiation. The results showed that the omission of radiotherapy led to an increased incidence of local breast cancer recurrence but had no negative effect on distant recurrence as the first event or overall survival. The study suggests that omission of radiotherapy could be a viable treatment option for older women with low-risk, hormone receptor–positive early breast cancer who receive adjuvant endocrine therapy.*

Article: Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

For many older breast cancer patients, study finds radiation doesn’t affect survival – STAT

Do Older Patients Need Radiation Rx After Breast Cancer Surgery? – HealthDay

 

*Note: This summary was created through the collaboration of a medical editor and ChatGPT.

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.